Over the past decade, cannabis legalization has become one of the most debated public health and social policy issues worldwide. While some countries have chosen to decriminalize cannabis possession, others have moved toward partial or full legalization. However, one key question remains: does legalization lead to increased cannabis use and addiction?<\/p>\n
A large international study published in The Lancet Psychiatry<\/em> in June 2026 offers important insights into this issue. Researchers examined changes in cannabis policies across different regions of the world between 2000 and 2025 and assessed their impact on cannabis consumption, addiction, and mental health.<\/p>\n One of the study\u2019s most notable findings is that decriminalization alone does not necessarily increase cannabis use. Researchers found that in countries and regions where possession for personal use was decriminalized, consumption rates remained largely unchanged. Similar results were observed in jurisdictions where cannabis is legal but its production and sale are strictly regulated by the government.<\/p>\n A clear example is Uruguay, which became the first country in the world to legalize cannabis in 2013. Today, the country maintains strict regulations. Adults can obtain cannabis only through licensed pharmacies, cannabis clubs, or limited home cultivation. This system allows the government to control product quality, potency, and availability. According to the study, Uruguay has not experienced a substantial increase in cannabis use since legalization.<\/p>\n A different picture emerges in countries with highly commercialized cannabis markets. Canada and several states in the United States have developed multi-billion-dollar cannabis industries. The study found that commercial legalization was associated with increases in both the number of users and the potency of cannabis products, particularly their concentration of tetrahydrocannabinol (THC), the compound responsible for most psychoactive effects. Rates of cannabis use disorder also increased.<\/p>\n According to the researchers, the issue is not legalization itself but commercialization. When private companies compete for profits, they tend to promote stronger, cheaper, and more accessible products. Similar patterns have been observed historically in the tobacco and alcohol industries. As a result, both consumption and health-related risks may rise.<\/p>\n The study also highlighted concerns regarding mental health. In regions with commercial cannabis markets, researchers observed an increase in hospitalizations related to psychosis. The risk appeared particularly high among individuals who regularly consume high-potency cannabis. Scientists emphasize that this association is especially important for adolescents and people with a genetic predisposition to psychiatric disorders.<\/p>\n At the same time, experts stress that cannabis policy debates should not focus solely on risks. Decriminalization can reduce criminal penalties and lessen the burden on the justice system. In several countries, policymakers argue that criminal sanctions for cannabis possession have disproportionately affected certain communities, whereas decriminalization allows the issue to be addressed primarily as a public health matter.<\/p>\n The review also examined the use of medical cannabinoids in mental health treatment. Researchers concluded that there is currently insufficient evidence to support cannabinoids as effective treatments for depression, anxiety disorders, or post-traumatic stress disorder. Limited benefits were observed only in certain conditions, such as some forms of insomnia.<\/p>\n Overall, current scientific evidence suggests that the consequences of cannabis legalization depend largely on how legalization is implemented. Decriminalization and tightly regulated state-controlled models do not appear to significantly increase cannabis use or addiction. In contrast, highly commercialized markets are associated with greater consumption, more potent products, and higher rates of addiction and mental health problems. According to experts, the key question is no longer whether cannabis should be legalized, but how it should be regulated to minimize risks to public health.<\/p>\n